Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT02114931. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis
Study identification
- NCT ID
- NCT02114931
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Amgen
- Industry
- Enrollment
- 467 participants
Conditions and interventions
Conditions
Interventions
- ABP 501 Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 81 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2014
- Primary completion
- Mar 31, 2016
- Completion
- Mar 31, 2016
- Last update posted
- Apr 23, 2017
2014 – 2016
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Covina | California | 91723 | — |
| Research Site | El Cajon | California | 92020 | — |
| Research Site | Hemet | California | 92543 | — |
| Research Site | Palm Desert | California | 92260 | — |
| Research Site | Van Nuys | California | 91405 | — |
| Research Site | Whittier | California | 90602 | — |
| Research Site | Danbury | Connecticut | 06810 | — |
| Research Site | Miami | Florida | 33015 | — |
| Research Site | Orlando | Florida | 32804 | — |
| Research Site | Sarasota | Florida | 34233 | — |
| Research Site | Sandy Springs | Georgia | 30328 | — |
| Research Site | Lexington | Kentucky | 40504 | — |
| Research Site | Hagerstown | Maryland | 21740 | — |
| Research Site | Wheaton | Maryland | 20902 | — |
| Research Site | St Louis | Missouri | 63141 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Brooklyn | New York | 11201 | — |
| Research Site | Mineola | New York | 11501 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Bethlehem | Pennsylvania | 18015 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Charleston | South Carolina | 29406 | — |
| Research Site | Memphis | Tennessee | 38119 | — |
| Research Site | Carrollton | Texas | 75007 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02114931, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 23, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02114931 live on ClinicalTrials.gov.